Metraipolis › archive › dc_458bf8a76ab3

Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical… — Europe PMC PMID:41754932

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41754932
DOI: 10.3390/pharmaceutics18020190
License (as archived): solo-consultazione
Archived: 2026-11-06T09:41:03.710Z
SHA-256 of the archived text: 7e59632ded58b995dca725dcc8d637265db29cc0fc2a834943abdbb2a27c645e
Stable URL of this page: https://metraipolis.com/documento/dc_458bf8a76ab3

How to cite

Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical… — Europe PMC PMID:41754932 — Europe PMC (en), https://europepmc.org/article/MED/41754932 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_458bf8a76ab3 (Metraipolis archive dc_458bf8a76ab3, sha256 7e59632ded58b995dca725dcc8d637265db29cc0fc2a834943abdbb2a27c645e)

BibTeX

@misc{dc458bf8a76ab3,
  title = {Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical… — Europe PMC PMID:41754932},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41754932},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_458bf8a76ab3; sha256 7e59632ded58b995dca725dcc8d637265db29cc0fc2a834943abdbb2a27c645e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754932. Agents can read the archived copy with the MCP tool read_document.